Ellen McErlean

4.1k citations
29 papers · 2.2k · 3 hit papers · h-index 17

Impact in

    • Cardiomyopathy and Myosin Studies
    • Acute Myocardial Infarction Research
    • Cardiovascular Function and Risk Factors
  • Immunology top 5%
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
    • Atherosclerosis and Cardiovascular Diseases

Papers in

    • Acute Myocardial Infarction Research 5
    • Cardiomyopathy and Myosin Studies 3
    • Cardiac Arrhythmias and Treatments 2
    • Cardiovascular Function and Risk Factors 2
    • Lipoproteins and Cardiovascular Health 6
    • Coronary Interventions and Diagnostics 3

Ellen McErlean

28 papers receiving 2.1k citations

Ellen McErlean's Hit Papers

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy 2022 · 203 citations
2030+7+15Years since publication250500750

Peers

Ellen McErlean
Comparison fields: 5 of 103
  • Cardiology and Cardiovascular Medicine 782
  • Immunology 446
  • Endocrinology, Diabetes and Metabolism 329
  • Surgery 570
  • Clinical Biochemistry 68
Replace Miguel Ángel Hernández-Presa with:
Miguel Ángel Hernández-Presa Spain
Jürgen Meyer Germany
Danish Saleheen Pakistan
Cheng‐Gang Zhu China
Yuan‐Lin Guo China
Na‐Qiong Wu China
Eak Kyun Shin South Korea
Ronnier J. Aviles United States
Gregory L. Pearce United States
Núria Plana Spain
Ellen McErlean relative to Miguel Ángel Hernández-Presa Spain Miguel Ángel Hernández-Presa's profile →
Citations per field
00.5×
Miguel Ángel Hernández-Presa · 1×
Citations per year

Countries citing papers authored by Ellen McErlean

Since Specialization
Citations

This map shows the geographic impact of Ellen McErlean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen McErlean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen McErlean more than expected).

Fields of papers citing papers by Ellen McErlean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen McErlean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen McErlean. The network helps show where Ellen McErlean may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen McErlean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen McErlean Line = papers co-authored together Ellen McErlean links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Hit paper breakdown →
2003850
2
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
Hit paper breakdown →
2011325
3
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Hit paper breakdown →
2022203
4 2007103
5 200494
6 202089
7 199987
8 201570
9 202255
10 200049
11 202243
12 202141
13 200033
14 200730
15 201828
16 202022
17 200617
18 200613
19 201912
20 200011

About Ellen McErlean

Ellen McErlean is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 29 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Acute Myocardial Infarction Research (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Coronary Interventions and Diagnostics (3 papers), Cardiomyopathy and Myosin Studies (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Cardiovascular Function and Risk Factors (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (782 citations), Immunology (446 citations), Endocrinology, Diabetes and Metabolism (329 citations), Surgery (570 citations) and Clinical Biochemistry (68 citations). Ellen McErlean has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Steven E. Nissen, Frederick Van Lente, Eric J. Topol, Michael Pepoy, Stanley L. Hazen, Marc S. Penn, Ronnier J. Aviles, Vijay Nambi, Marie‐Luise Brennan and Marlene Goormastic. Their work appears in journals such as American Heart Journal, Circulation, Journal of the American College of Cardiology, The Journal of Cardiovascular Nursing and JAMA Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact